UNBELIEVABLE: 2 - The Untold Story

EU regulators greenlight twice-yearly HIV injection, hailed as medical breakthrough

The drug is expected to be formally approved by the European Commission this year.

Euronews · Jul 25, 2025

DTM Norisring: Preining triumphs in chaotic race from Aitken

Manthey Porsche driver Thomas Preining clinched victory in the second DTM race of the Norisring round.

Autosport · Jul 6, 2025

DTM Norisring: Thomas Preining wins chaotic race

Manthey Porsche driver Thomas Preining clinched victory in the second race of the Norisring round in the 2025 DTM season.

Motorsport · Jul 6, 2025

Men’s hair loss treatment linked to rare risk of suicidal thoughts, EU medicines regulator says

The medicine will remain on the shelves but will come with additional warnings about the side effects, which appear to be rare.

Euronews · May 8, 2025

EU agency flags risks to nuclear medicines from dependency on Russia and US

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).

Euronews · Apr 15, 2025

EU regulators block new Alzheimer’s drug citing potentially fatal side effects

The company behind the drug donanemab said it will ask regulators to reconsider the decision.

Euronews · Mar 28, 2025

Addressing Challenges in Rare Disease Clinical Trials: Strategies for Success with iNGENū CRO

iNGENū CRO leverages global expertise, advanced technology, and strategic funding to overcome rare disease trial challenges.

Medical Daily · Mar 26, 2025

Beware of unproven cancer treatments advertised online, EU medicine regulators say

The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally.

Euronews · Mar 20, 2025

3 High-Conviction Stocks with Strong Buy Ratings from Analysts

It’s easy to get caught up in market noise, but investing in companies backed by strong fundamentals and long-term growth potential can help investors stay the course even during market volatility. Thus, one could consider adding these three high-conviction pharmaceutical stocks, AbbVie (ABBV), Merck & Co. (MRK), and Bristol-Myers Squibb…

StockNews.com · Feb 4, 2025

3 Biotech Stocks With Promising Pipelines

The biotech sector’s AI-driven advancements, personalized medicine demand, and streamlined regulations fuel significant market growth. Hence, investors should consider robust biotech stocks such as Vertex Pharmaceuticals (VRTX), Amgen (AMGN), and Gilead Sciences (GILD). Read on.

StockNews.com · Dec 12, 2024